AbCellera Biologics Inc. ABCL Return on invested capital

Return on invested capital at other companies

SchrodingerSDGR

-83.1%+94.1pp

Twist Bioscience CorporationTWST

-36.4%-9.3pp

Recursion Pharmaceuticals, Inc.RXRX

-116.4%-30.6pp

Ginkgo BioworksDNA

-40.3%-8.7pp

Absci CorporationABSI

-80.3%+11.1pp

Avalo TherapeuticsAVTX

-42.9%—

FAQ

What is AbCellera Biologics Inc.'s return on invested capital?

AbCellera Biologics Inc. (ABCL) reported return on invested capital of -23.5% in Q2 2026.

How has AbCellera Biologics Inc.'s return on invested capital changed year-over-year?

AbCellera Biologics Inc.'s return on invested capital increased by 14.0% year-over-year, from -27.3% to -23.5%.

What is the long-term trend for AbCellera Biologics Inc.'s return on invested capital?

Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s return on invested capital has grown at a -13.5% compound annual growth rate (CAGR), from 34.5% to -22.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.